Compassionate Use of Evinacumab

N/AApproved For MarketingNCT06500598

Regeneron Pharmaceuticals

Overview

Provide compassionate use of evinacumab

Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications. Availability will depend on location.

Study Type

EXPANDED_ACCESS

Conditions

Pediatric Homozygous Familial Hypercholesterolemia (HoFH)Severe Hypertriglyceridemia (HTG)Dysbetalipoproteinemia (DBL)

Interventions

EvinacumabDRUG

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.